Shetty Reshma P.'s Form 4 filing
Ginkgo Bioworks Holdings, Inc. (DNA) · filed Apr 13, 2026
- Accession no.
- 0001628280-26-024927
- Filed
- Apr 13, 2026
- Trade date
- Apr 9-10, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $802.0K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Shetty Reshma P.CIK 0001873523 | Director, Officer (See remarks), 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 9, 2026 | Class A Common Stock | MOption exerciseAcquired | +251,786 | – | – | 561,149 | Direct | |
| Apr 10, 2026 | Class A Common Stock | SSaleDisposed | −124,727 | $6.43 | −$801,994.61 | 436,422 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 9, 2026 | Class A Common Stock | MOption exerciseDisposed | −251,786 | – | – | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.